COVID-19 Research Resources
This page is the comprehensive hub for resources related to COVID-19 research at USC or externally, including funding agency guidelines, available datasets, computing resources, reports, tools, core facilities and equipment and more.
Below you can find federal, non-federal and internal funding opportunities for COVID-19 research. To add a funding opportunity or update the listing for one below, please fill out our Funding Opportunities Form.
|Deadline||Title||Sponsored By||Amount||Date Posted|
|2024/02/02||RFA-NS-23-022 - Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional)||National Institutes of Health (NIH)||See solicitation for details||2023/03/29|
|2024/02/02||RFA-NS-23-021 - Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional)||National Institutes of Health (NIH)||See solicitation for details||2023/03/29|
|2026/05/08||NOT-DE-23-004 - Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19)||National Institutes of Health (NIH)||See solicitation for details||2023/03/08|
|2023/05/31||NOT-OD-23-040 - Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21)||National Institutes of Health (NIH)||See solicitation for details||2023/12/19|
|2025/07/06||NOT-HL-23-080 - Enhancing Research on Deciphering Mechanisms of COVID-19-Associated Coagulopathy||National Institutes of Health (NIH)||See solicitation for details||2023/02/23|
|2023/06/02||NOT-NS-23-069 - Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R21 Clinical Trial Optional)||National Institutes of Health (NIH)||See solicitation for details||2023/02/23|
|2023/06/02||NOT-NS-23-068 - Understanding Neurological Effects of COVID-19 and Post-Acute Sequelae of SARS-CoV-2 Infection (R01 Clinical Trial Optional)||National Institutes of Health (NIH)||See solicitation for details||2023/02/23|
|2023/02/20||NOT-OD-23-041 - Research Supplements to Promote Data Science Workforce Diversity to Reveal Scientific Insights of COVID-19 Testing Technologies (Admin Supp Clinical Trial Not Allowed)||National Institutes of Health (NIH)||See solicitation for details||2022/12/19|
|2023/01/17||RFA-FD-23-009 - Innovation Award: COVID-19 and Health Equity (U01) Clinical Trials Not Allowed||National Institutes of Health (NIH)||See solicitation for details||2022/11/09|
|2022/08/20||NOT-NS-23-001 - COVID-19 Related Revisions to NINDS ADRD Human Subjects Cooperative Agreement Programs||National Institutes of Health (NIH)||See solicitation for details||2022/06/21|
|2022/08/30||Peter G. Peterson Foundation Pandemic Response Policy Research Fund - Supporting research that advances our understanding of the short and long-run impact of public policies implemented in response to the pandemic.||Schaeffer Center||$150,000||2022/05/11|
|2024/06/06||NOT-HD-22-003 - Notice of Special Interest (NOSI) - Administrative Supplements for Research of Emerging and Existing Issues of COVID-19 Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities||National Institutes of Health (NIH)||See solicitation for details||2022/04/22|
|2024/06/06||NOT-HD-22-003 - Administrative Supplements for Research of Emerging and Existing Issues of COVID-19 Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities||National Institutes of Health (NIH)||See solicitation for details||2022/04/19|
|2022/04/20||RFA-OD-22-011 - Emergency Award: Rapid Acceleration of Diagnostics Tribal Data Repository (RADx TDR) (U24 Clinical Trial Not Allowed)||National Institutes of Health (NIH)||See solicitation for details||2022/04/11|
|2022/06/01||NOT-DK-22-017 - Availability of Urgent Competitive Revisions for Epidemiologic Studies of Diabetes Incidence and Severity and Its Potential Association with COVID-19||National Institutes of Health (NIH)||See solicitation for details||2022/04/01|
|2022/06/06||NOT-ES-22-005 - Promoting Health, Safety, and Recovery Training for COVID-19 Essential Workers and their Communities||National Institutes of Health (NIH)||See solicitation for details||2022/03/30|
|2024/06/06||NOT-HD-22-002 - Emerging and Existing Issues of Coronavirus Disease 2019 (COVID-19) Research Related to the Health and Well-Being of Women, Children and Individuals with Physical and/or Intellectual Disabilities||National Institutes of Health (NIH)||See solicitation for details||2022/03/28|
|2022/12/20||NOT-DK-22-018 - Notice of Intent to Publish a Funding Opportunity Announcement for Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed)||National Institutes of Health (NIH)||See solicitation for details||2022/03/23|
|2022/05/09||RFA-IP-22-004 - US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings||National Institutes of Health (NIH)||See solicitation for details||2022/03/08|
|2022/05/03||RFA-OD-22-006 - Emergency Award: RADx-UP Community-Engaged Research on Rapid SARS-CoV-2 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)||National Institutes of Health (NIH)||See solicitation for details||2022/02/17|
|2022/05/03||RFA-OD-22-005 - Emergency Awards: RADx®-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional)||National Institutes of Health (NIH)||See solicitation for details||2022/02/17|
|2022/02/23||NOT-NR-22-009 - Pre-Application Webinar for Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) (RFA-NR-22-001)||National Institutes of Health (NIH)||See solicitation for details||2022/02/08|
|2022/03/07||NOT-EY-22-010 - Notice of Special Interest (NOSI): Addressing Accessibility Inequities with COVID Home-Based Testing for Individuals with Visual Impairment||National Institutes of Health (NIH)||See solicitation for details||2022/02/04|
|2022/04/15||NOT-FD-22-006 - FDA Notice of Special Interest (NOSI) to add COVID-19 Capacity Building Grants to PAR-18-604 Vet-LIRN Network Capacity-Building Projects (Vet-LIRN)||National Institutes of Health (NIH)||See solicitation for details||2022/02/02|
|2022/03/25||PAR-22-113 - Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Optional)||National Institutes of Health (NIH)||See solicitation for details||2022/01/31|
|2022/03/25||PAR-22-112 - Urgent Award: COVID-19 Mental Health Research (R01 Clinical Trial Required)||National Institutes of Health (NIH)||See solicitation for details||2022/01/31|
|2022/04/07||RFA-NR-22-001 - Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional)||National Institutes of Health (NIH)||See solicitation for details||2022/01/25|
|2022/03/01||RFA-DE-22-011 - HEAL Initiative: Secondary Analysis and Integration of Existing Data Related to Acute and Chronic Pain Development or Management in Humans (R21 Clinical Trials Not Allowed)||National Institutes of Health (NIH)||See solicitation for details||2022/01/21|
|2022/03/22||NOT-GM-22-026 - Notice of Special Interest (NOSI): Urgent Competitive Revisions to IDeA and NARCH Programs for SARS-CoV-2 Surveillance Studies||National Institutes of Health (NIH)||See solicitation for details||2022/01/21|
|2022/03/22||NOT-HL-23-003 - Notice of Special Interest (NOSI): Enhancing Research on Deciphering Mechanisms of COVID-19-Associated Coagulopathy||National Institutes of Health (NIH)||See solicitation for details||2022/01/21|
|2025/01/08||NOT-MH-22-100 - Notice of Special Interest (NOSI): COVID-19 Pandemic Mental Health Research||National Institutes of Health (NIH)||See solicitation for details||2022/01/19|
|2023/01/08||NOT-AR-22-012 - Promoting Research on COVID-19 and Rheumatic, Musculoskeletal and Skin Diseases||National Institutes of Health (NIH)||See solicitation for details||2021/12/28|
|2023/01/08||NOT-MD-22-006 - Notice of Special Interest (NOSI): Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities||National Institutes of Health (NIH)||See solicitation for details||2021/12/21|
|2025/09/08||NOT-HL-22-004 - Pediatric COVID-19 and Respiratory Viral Co-infection||National Institutes of Health (NIH)||See solicitation for details||2021/12/21|
|2023/04/27||NOT-HS-21-014 - The Agency for Healthcare Research and Quality (AHRQ) is interested in supporting health services research to develop, disseminate and implement evidence-based interventions to address documented healthcare inequities, especially those that have been made even more apparent by the COVID-19 pandemic and the stark disproportionate impact of COVID-19 on Black and other minority communities.||National Institutes of Health (NIH)||See solicitation for details||2021/05/12|
|2024/05/08||NOT-HD-21-026 - The COVID pandemic has resulted in unprecedented health, social and economic conditions significantly changing the ecological context for children and families. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) recognizes that the need to study ways to strengthen and/or develop new channels of communication between and among reporting systems and systems of care for children at risk of abuse and/or neglect is paramount.||National Institutes of Health (NIH)||See solicitation for details||2021/05/12|
|Rolling||NOT-AI-21-05 - To help support NIAID trainees, National Institute of Allergy and Infectious Diseases (NIAID) is providing an opportunity for select F award recipients in the last year of their award to apply for a funded extension to support their career development to facilitate successful transition to research independence.||National Institutes of Health (NIH)||See solicitation for details||2021/05/12|
|Rolling||NOT-AI-21-051 - The National Institute of Allergy and Infectious Diseases (NIAID) is providing an opportunity for select K award recipients in the last year of their award, or in their first no-cost extension, to apply for a funded extension to support their career development to facilitate successful transition to research independence. Due to limited funding in FY2021, the NIAID will not be able to provide funded extensions for all K awardees.||National Institutes of Health (NIH)||See solicitation for details||2021/05/12|
|2024/06/08||NOT-OD-21-100 - The NIH calls for research grant applications that address patient adherence to treatment and prevention regimens to promote health outcomes, including COVID-related issues.||National Institutes of Health (NIH)||See solicitation for details||2021/04/09|
|2022/09/08||NOT-MH-21-225 - The National Institute of Mental Health (NIMH) is issuing this Notice of Special Interest (NOSI) to highlight interest in research to understand the mental health impact of the Coronavirus Disease 2019 (COVID-19) pandemic on school-aged children, specifically ages 3 – 12.||National Institutes of Health (NIH)||See solicitation for details||2021/04/02|
|Rolling||NOT-OD-21-097- The NIH plans to publish a Research Opportunity (RO) as part of the Rapid Acceleration of Diagnostics for Underserved Populations (RADxSM-UP) initiative to solicit research on COVID-19 diagnostic testing approaches to safely return children and staff to the in-person school setting in underserved and vulnerable communities.||National Institutes of Health (NIH)||See solicitation for details||2021/04/02|
|2023/05/08||NOT-AG-21-016 - The National Institute on Aging (NIA) announces its interest in basic and clinical mechanistic research on neurological and neurocognitive sequelae originating from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and Coronavirus Disease 2019 (COVID-19) in aging and age-related neurodegeneration.||National Institutes of Health (NIH)||See solicitation for details||2021/03/03|
|2024/08/17||NOT-TR-21-022 - The National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for projects that address the COVID-19 Public Health Emergency.||National Institutes of Health (NIH)||See solicitation for details||2021/03/03|
|2024/09/08||NOT-DA-21-017 - National Institute on Drug Abuse (NIDA) is interested in receiving research applications focusing on individuals with HIV who smoke or vape marijuana, tobacco, cocaine and/or methamphetamine to determine the long-term effects of their use among individuals with HIV and COVID-19.||National Institutes of Health (NIH)||See solicitation for details||2021/02/04|
|2024/08/17||NOT-TR-21-017 - The National Center for Advancing Translational Sciences (NCATS) is issuing this notice to highlight the urgent need for projects that address the COVID-19 Public Health Emergency.||National Institutes of Health (NIH)||See solicitation for details||2021/02/03|
|2024/09/08||NOT-DA-21-018 - The National Institute on Drug Abuse (NIDA) is interested in receiving research applications focusing on studying the long-term neurocognitive consequences of the COVID-19/HIV/SUDs syndemic.||National Institutes of Health (NIH)||See solicitation for details||2021/02/03|
|Rolling||NOT-OD-21-052 - The NIH is providing an opportunity for recipients of NIH Fellowship (“F”) and NIH Career Development (“K”) awards who have been impacted by COVID-19 to request extensions.||National Institutes of Health (NIH)||See solicitation for details||2021/02/02|
|2023/06/02||NOT-MH-21-120 - The National Institute of Mental Health (NIMH) is providing supplemental funding to investigators and institutions with active National Institute of Mental Health (NIMH) awards that have been significantly impacted by the COVID-19 pandemic.||National Institutes of Health (NIH)||See solicitation for details||2020/12/23|
|2024/09/08||NOT-DA-20-084 - The purpose of this notice is to communicate NIDA’s (National Institute on Drug Abuse) interest in supporting research on the effects of smoking or vaping tobacco or marijuana on the risk of acquiring COVID-19 and the clinical course of the infection.||National Institutes of Health (NIH)||See solicitation for details||2020/10/27|
|2023/05/08||NOT-HD-20-031 - The purpose of this NOSI is to encourage applications in three areas related to the intersection of COVID-19, the associated mitigation actions, and rehabilitation. Research applications addressing these topics are considered responsive; not all topics are expected within the same application.||National Institutes of Health (NIH)||See solicitation for details||2020/09/29|
|2023/05/08||NOT-MD-20-025 - The purpose of this Notice of Special Interest is to support investigative and collaborative research focused on developing and evaluating simulation modeling and systems science to understand and address minority health and health disparities.||National Institutes of Health (NIH)||See solicitation for details||2020/08/13|
Funding Agency Guidelines
10/25/22 NOT-OD-23-008 – Clarification and Guidance for Applicants Preparing Applications for the FALL 2022 Due Dates During the COVID-19 Pandemic
10/25/22 NOT-OD-23-006 – Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: May 2023 Councils
10/05/22 NOT-HD-22-047 – Notice of Training and REDCap Demonstration for the Implementation of NICHD’s CDE Recommendations for COVID-19 Research in Pediatric, Pregnant, and Lactating Populations Published Through the NIEHS Disaster Research Response (DR2) Portal
03/15/22 NOT-OD-22-092 – Request for Information (RFI): Inviting comments to inform the National Institutes of Health (NIH) on the intersection of the SARS-CoV-2/COVID-19 pandemic and the health of women
02/04/22 NIH NOT-OD-22-062 – Further Continuation of Temporary Extension of Eligibility for the NIH K99/R00 Pathway to Independence Award During the COVID-19 Pandemic
12/27/21 NIH NOT-OD-22-046 – Clarification and Guidance for Applicants Preparing Applications for the Spring 2022 Due Dates During the COVID-19 Pandemic
12/27/21 NIH NOT-OD-22-047 – Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: August/October 2022 Councils
BIO COVID-19 Therapeutic Development Tracker
BIO’s Industry Analysis Team has reviewed and annotated pipeline data from BioCentury and Biomedtracker to create a granular, interactive view of the Covid-19 pipeline. The team has investigated each drug as to original inventor (company/country), mechanism of action and strategic approach, as well as de-duplicated multiple company and university programs for the same active ingredient (for example, hydroxychloroquine is counted only once).
CDC National Center for Heath Statistics, Provisional Death Counts for Coronavirus Disease (COVID-19)
The provisional counts for coronavirus disease (COVID-19) deaths are based on a current flow of mortality data in the National Vital Statistics System.
CDC National Center for Heath Statistics, Laboratory-Confirmed COVID-19-Associated Hospitalizations
The Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET) conducts population-based surveillance for laboratory-confirmed COVID-19-associated hospitalizations in children (persons younger than 18 years) and adults.
Coronavirus Knowledge Hub
An up-to-date source of trusted information and analysis on COVID-19 and coronaviruses.
COVID-19 Data Archive
COVID-ARC helps address the immediate need to understand the spread and impact of COVID-19 with a platform of networked and centralized archives that store, curate, visualize, and disseminate multimodal data related to the disease. The platform includes patients’ demographics, clinical evaluations, vitals, EKGs, and imaging data, such as CT, X-Ray, PET, and MRI. COVID-ARC data, together with a variety of analytic tools, are shared broadly with the world-wide scientific community. This will help maximize the potential for research progress by uniting scientists from diverse fields, including medicine, public health, and artificial intelligence.
COVID-19 Neuro Databank/Biobank (NeuroCOVID)
A new database will collect information from clinicians about COVID-19-related neurological symptoms, complications, and outcomes as well as COVID-19 effects on pre-existing neurological conditions. NeuroCOVID will be a resource of clinical information as well as biospecimens from people of all ages who have experienced neurological problems associated with SARS-CoV-2 infection. The database is supported by the NIH.
COVID-19 Open Research Dataset (CORD-19)
In response to the COVID-19 pandemic, the Allen Institute for AI has partnered with leading research groups to prepare and distribute the COVID-19 Open Research Dataset (CORD-19), a free resource of over 29,000 scholarly articles, including over 13,000 with full text, about COVID-19 and the coronavirus family of viruses for use by the global research community.
The iSearch COVID-19 portfolio is NIH’s comprehensive, curated source for publications related to COVID-19. This portfolio includes articles from PubMed and pre-prints from arXiv, medRxiv, bioRxiv, and ChemRxiv. It’s updated daily with the latest available data.
COVID-19 SeroHub initially contains data from 40+ seroprevalence studies conducted in the U.S. by the CDC, NIH, state and local health departments, universities, and other sources. Studies will be added to the hub as they become available.
Data harmonization and sharing are essential for COVID-19 research
NIA staff are collaborating with NIH colleagues to coordinate and catalogue the large number of pandemic-specific questionnaires, modules, and scales about COVID-19 experiences and impacts, and to discourage the development of one-off survey instruments.
Johns Hopkins Coronavirus Map & Resource Center
The map was first shared publicly on Jan. 22. It was developed to provide researchers, public health authorities, and the general public with a user-friendly tool to track the outbreak as it unfolds. All data collected and displayed are made freely available through a GitHub repository, along with the feature layers of the dashboard, which are now included in the ESRI Living Atlas.
Medical Imaging and Data Resource Center
MIDRC has launched a repository of imaging data to facilitate medical imaging research on COVID-19. The eventual repository—to include CT scans and x-rays— is planned to be to the largest open database of anonymized COVID-19 medical images, along with associated clinical data, in the world. The imaging data is a free resource for research and education communities world-wide to study, use in development of artificial intelligence (AI) and deep learning tools, and serve as a reference to enhance clinical recognition of COVID-19.
NCBI SARS-CoV-2 Resources
Are you trying to keep up with the rapidly growing number of biological resources associated with the SARS-CoV-2 virus and the related disease, COVID-19? Find SARS-CoV-2-related content available at NCBI. It will help bench scientists, bioinformaticians, clinicians, and others connect with the information they need to study SARS-CoV-2 and end the COVID-19 pandemic.
USC Libraries: Coronavirus (COVID-19)
Resources for COVID-19 information at USC Libraries including Public Health National & International Government Coronavirus Resources for Health Professionals, Coronavirus Research Portals, and Other Coronavirus Resources for Healthcare Professionals.
COVID-19 High Performance Computing Consortium
The Trump administration has unveiled a new initiative to help researchers worldwide harness a range of America’s most powerful high-performance supercomputing resources to deliberately accelerate new discoveries in the fight against COVID-19. Scientists can tap into 16 of America’s top computing systems.
Vaccine Research and Development to Advance Pandemic and Seasonal Influenza Preparedness and Response: Lessons from COVID-19
Focuses on how to leverage the knowledge gained from the COVID-19 pandemic to optimize vaccine research and development (R&D) to support the prevention and control of seasonal and pandemic influenza. The committee’s findings address four dimensions of vaccine R&D: (1) basic and translational science, (2) clinical science, (3) manufacturing science, and (4) regulatory science.
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development
This report examines these vaccines and the related research effort, both traditional and forward-looking, to illustrate the advantages and disadvantages of their technologies, to denote the use of adjuvants and delivery systems in their application, and to provide a perspective on their future direction.
Against Pandemic Research Exceptionalism
Crises are no excuse for lowering scientific standards.
Bioinformatics Self-learning Resources Guide
Compiled for researchers who are interested in learning how to carry out some of the most common bioinformatics tasks. This resource provides links to previous workshops and training on their licensed commercial bioinformatics software. It also includes links to a hand-picked list of high-quality publicly accessible bioinformatics tutorials and webinars from other institutions, focusing on open-source tools.
Candid has created a pop-up webpage with Funding summary, Funding opportunities, Webinars, News, Blog posts, External resources, etc to get you the information you need to do good during the novel coronavirus (COVID-19) pandemic. They invite nonprofits seeking support because of the crisis, funders who wish to learn what their peers are doing, the media, and all who wish to know more about philanthropy’s response to the pandemic to take advantage of this resource.
Coronavirus: Research, Commentary, and News
The Science journals are striving to provide the best and most timely research, analysis, and news coverage of COVID-19 and the coronavirus that causes it. All content is free to access.
COVID-19 Testing Strategies for Colleges and Universities
States that testing programs need to be designed to match the needs of specific institutions and identifies fast, frequent testing as one useful tool to mitigate the spread of COVID-19 in a large and diverse university community.
Encouraging Protective Covid-19 Behaviors Among College Students
Uses the science of adolescent development to explore how colleges can most effectively encourage students to adopt behaviors that help prevent spread of the virus, such as mask wearing and physical distancing.
Eric Topol’s Twitter
Eric Topol is an American cardiologist, geneticist, author, and scientist. He is the Founder and Director of the Scripps Research Translational Institute in La Jolla, California.
Interlibrary Loan and Document Delivery (IDD): COVID-19 and IDD
The USC Libraries has been actively supporting researchers during our time off campus, providing support to faculty to move their course content online and providing digital content and physical materials for their research as well.
Joint Acquisition Task Force (JATF)
Led by Stacy Cummings, the Principal Deputy Assistant Secretary of Defense for Acquisition — has been established to integrate DOD, HHS, DHS, and FEMA support for COVID-related requirements. JATF has created a portal where companies can propose solutions to government needs, with an initial focus on medical and pharmaceutical requirements.
Just One Giant Lab
A “decentralized open research and innovation laboratory” that is encouraging the global scientific community to join the Open-COVID-19 Initiative, an “open source methodology to safely test for the presence of SARS-CoV-2 using tools as common as possible.”
National Academy of Engineering (NAE) Call for COVID-19 Action Platform
NAE has created an incubator initiated in a Slack platform for the Grand Challenges Scholars Program (GCSP) and Frontiers of Engineering (FOE) communities, along with others, to collectively brainstorm on potentially innovative engineering ideas that could help ameliorate the virus itself and/or its collateral discontinuities, such as impacts on the supply chain and closure of schools.
National Academies of Sciences, Engineering, and Medicine
Each year, thousands of the world’s leading experts participate in our projects, studies, and other advisory and convening activities to examine and assemble evidence-based findings to address some of society’s toughest challenges. In addition, the National Academies pursue a wide range of activities to strengthen the scientific, engineering, and medical fields and their capacity to contribute to human welfare.
National Endowment for the Humanities (NEH)
NEH received $75 million in supplemental funding to assist cultural institutions and humanists affected by the coronavirus as part of the $2.2 trillion CARES Act economic stabilization plan.
National Summit on the Science and Technology of Epidemiological Modeling and Prediction
The White House Office of Science and Technology Policy (OSTP) asked the Science and Technology Policy Institute (STPI) to support the National Summit on the Science and Technology of Epidemiological Modeling and Prediction (Summit), which was held in a virtual format on November 12–13, 2020.
The free and open Project PREPARE resource is a virtual organization to facilitate communication and collaboration among the community conducting pandemic research, supported by NSF CISE.
Research Ethics Consultation During the Coronavirus Pandemic
There are many ways in which the COVID-19 pandemic is raising new and challenging ethical issues for researchers. If you have questions regarding research ethics, clinical ethics, or bioethics, please feel free to contact the Office of Research Integrity and we will do our best to find resources that might help you in your research endeavors.
Running a Lab in the New Normal
Dr. Adam Leventhal, Director of the University of Southern California’s Institute for Addiction Science, highlights the impact of COVID-19 on research labs across the country. His experience as a PI of multiple labs, advice from colleagues, and #AcademicTwitter all contribute to the key takeaways in this presentation including best practices for running a lab remotely, tips for adapting to the COVID-19 related structural and emotional changes, and ways to pivot and be flexible along the way.
Societal Experts Action Network
The COVID-19 pandemic and the associated recession have significantly affected women’s workforce participation. While these impacts have varied by sector and family status, Black and Hispanic women have been particularly affected, bringing into sharp relief historical gender and racial inequities in the labor market. New guidance from the Societal Experts Action Network identifies strategies that state and local decision makers can use to assist in short-term recovery efforts for women whose employment status and work experiences have been affected by the COVID-19 pandemic.
To add your information, please click here.
If you have questions about a core facility’s operations or status, please contact the core facility.
Biosafety Level 3 Laboratories – Tom Buchanan,
Lucio Comai, Jill Henley
To get involved in research using the COVID-19 virus in BSL3 Containment Facility: At this point facilities are available only for in vitro cell culture studies, not in vivo animal models. Proposing research groups beed to have their staff trained and certified to conduct the research. To initiate the application process, email Tom Buchanan, Lucio Comai, Jill Henley. BSL3 Containment Facility Services include SOP training, work flow guidance, sample storage and basic laboratory equipment. All research involving COVID-19 virus (SARS-CoV-2), including clinical specimens that might contain the virus, must be reviewed and approved by the USC Institutional Biosafety Committee.
Center of Excellence in NanoBiophysics – Shuxing Li
For the new test kit and compound design and development, the Center provide instruments including Microplate reader, Biacore, ITC to study the interaction between protein-protein, protein-compound and protein-DNA.
CTSI – Biostatistics, Epidemiology and Research Design (BERD) – Wendy Mack
The BERD team can assist investigators with the conduct, interpretation and summary of statistical analyses.
CTSI – Clinical Research Informatics (CRI) – Neil Bahroos
CRI provides services enabling complete access and analysis of patient data from the electronic medical records of Keck Medicine of USC, Children’s Hospital of Los Angeles, and the Los Angeles Department of Health Services.
CTSI – Clinical Research Support (CRS) – Tali Homsey
Clinical Research Coordinator Pool who provide study-related services ranging from regulatory document preparation, participant recruitment, data collection and entry, and study monitoring.
CTSI – Clinical Trials Unit (CTU) – Thao Rodriguez
The CTU employs highly qualified research staff to meet all of your human study needs, such as skilled research nurses, research phlebotomists, lab technicians, and radiology technicians.
Keck Genomics Platform – Zarko Manojlovic
Genomics has essentially become the center of discovery and translational research across the globe. The importance of nucleic acid perturbations are all but ubiquitous as we move to understand the etiology of most human diseases and conditions. The ability to understand such complex conditions at its core will ultimately contribute to improvements in medical treatments and healthier communities.
Translational Imaging Center – Jason Junge
Live imaging of infected cells and tissues, including metabolic imaging. Stryker Treacheoscope for metabolic imaging in human airways. Olympus Bronchoscope for metabolic imaging of airways of animal models.
Translational Research Laboratory (TRLab) – Junji Watanabe
TRLab is equipped with over 50 specialized instruments in applications of: 1) automated sample processing (KingFisher, Pipet Robot), 2) Histology, 3) cell and Immunobiology (MSD, Luminex, Seahorse), 4) flow cytometry (analyzer & sorter), 5) imaging (microscopes, HTS plate/slide scan), 6) molecular analysis (plate readers, spectrometers), 7) Molecular Biology (Qubit, Bioanalyzer, TapeStation, qPCR) and 8) sequencing (MiSeq NGS).
USC COVID-19 Biospecimen Repository – Sue Ellen Martin
Procurement, processing, and storage of biospecimens from patients and appropriate controls to support researcch on COVID-19 in a CAP/CLIA certified environment. Biospecimens to include bronchial washings and brushings, bronchial FNA and core biopsy specimens, whole blood, serum, plasma, peripheral blood mononuclear cells, other as requested.
USC Research Slack Channel
Visit our Slack channel to share ideas and solicit collaborations about COVID-19 research or other research.
COVID-19 Research Events
Upcoming COVID-19 research events and training at USC (or of significant importance outside USC) can be found on our Events page.